Hong Pan
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Lung Cancer Treatments and Mutations 2
- Ferroptosis and cancer prognosis 1
- Photodynamic Therapy Research Studies 1
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Wenbin Zhou (13 shared papers)Qiang Ding (9 shared papers)Xiaoan Liu (7 shared papers)Lijun Ling (6 shared papers)Shui Wang (3 shared papers)Shui Wang (7 shared papers)Mengdi Liang (4 shared papers)Ge Ma (3 shared papers)
In The Last Decade
Hong Pan
22 papers receiving 499 citations
Peers
Comparison fields: 5 of 70
- Hepatology 48
- Oncology 150
- Cancer Research 78
- Immunology 106
- Biotechnology 24
Countries citing papers authored by Hong Pan
This map shows the geographic impact of Hong Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong Pan more than expected).
Fields of papers citing papers by Hong Pan
This network shows the impact of papers produced by Hong Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong Pan. The network helps show where Hong Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Hong Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 64 | |
| 2 | 2013 | 55 | |
| 3 | 2020 | 49 | |
| 4 | 2018 | 45 | |
| 5 | 2013 | 41 | |
| 6 | 2021 | 41 | |
| 7 | 2023 | 37 | |
| 8 | 2024 | 33 | |
| 9 | 2014 | 33 | |
| 10 | 2013 | 24 | |
| 11 | 2018 | 21 | |
| 12 | 2021 | 17 | |
| 13 | 2021 | 10 | |
| 14 | 2019 | 9 | |
| 15 | 2021 | 6 | |
| 16 | 2025 | 5 | |
| 17 | 2022 | 4 | |
| 18 | 2021 | 3 | |
| 19 | 2016 | 2 | |
| 20 | 2025 | 2 |
About Hong Pan
Hong Pan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Immunology, Molecular Biology and Sociology and Political Science, having authored 26 papers that have together received 504 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Immunotherapy and Immune Responses (3 papers), Land Use and Ecosystem Services (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Lung Cancer Treatments and Mutations (2 papers), Ferroptosis and cancer prognosis (1 paper), Photodynamic Therapy Research Studies (1 paper) and Single-cell and spatial transcriptomics (1 paper). The work is most often cited by research in Hepatology (48 citations), Oncology (150 citations), Cancer Research (78 citations), Immunology (106 citations) and Biotechnology (24 citations). Hong Pan has collaborated with scholars based in China, Hong Kong and Germany. Frequent co-authors include Wenbin Zhou, Qiang Ding, Xiaoan Liu, Lijun Ling, Shui Wang, Shui Wang, Mengdi Liang, Ge Ma, Muxin Yu and Yanni Jiang. Their work appears in journals such as PLoS ONE, Journal for ImmunoTherapy of Cancer, Annals of Oncology, Cellular and Molecular Immunology and Diagnostic and Interventional Imaging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.